Results

Total Results: 1,060 records

Showing results for "policymakers".

661. Prenatal Screening Written Statement (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-170-prenatal-screening-written-statement.pdf
     June 02, 2025 - Prenatal Screening Written Statement

662. Impact of a pediatric-focused medical home learning collaborative on preventable emergency department visits by publicly-insured children in Massachusetts (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-medical-home-academyhealth.pdf
     December 12, 2015 - Impact of a pediatric-focused medical home learning collaborative on preventable emergency department visits by publicly-insured children in Massachusetts Impact of a pediatric-focused medical home learning collaborative on preventable emergency department visits by publicly- insured children in Massachusetts Pau…

663. PMCoE PICU Expert Work Group and Leadership Team Roster (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-203-section-6-b-workgroup.pdf
     September 18, 2014 - PMCoE PICU Expert Work Group and Leadership Team Roster …

664. Chart Abstraction Form (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-203-section-2-tech-specs.pdf
     December 14, 2011 - Chart Abstraction Form Basic Elements Patient ID Race Ethnicity Gender Payer Preferred Language Age upon admission (YEARS) [e.g. for 12.5 year old, years = 12) Age upon admission (MONTHS) [ e.g. for 12.5 year old, months = 6] 1 White Non-Hispanic Female Medicaid English …

665. Value Set Export (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-169-gestational-age-additional-specifications.pdf
     January 01, 2012 - Value Set Export Copyright 2012 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Im…

666. Chipra-169-Gestational-Age-Written-Statement (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-169-gestational-age-written-statement.pdf

667. Graphics for Section 6B, Validity (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-6-b.pdf
     November 26, 2013 - Graphics for Section 6B, Validity                                                                                               Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for Section VI. Scient…

668. Graphics for Section 7, Identification of Disparities (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-a.pdf
     November 26, 2013 - Graphics for Section 7, Identification of Disparities                                                                                           Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for Section VII…

669. Graphics for Section 7C. Socioeconomic Status (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-c.pdf
     November 26, 2013 - Graphics for Section 7C. Socioeconomic Status                                                                                                 Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for Section VII. Identificat…

670. Graphics for Section 1. Basic Measurement Information (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-1.pdf
     November 26, 2013 - Graphics for Section 1. Basic Measurement Information                                                                                                            Q‐METRIC Sickle Cell Disease Measure …

671. Graphics for Section 5. Evidence or Other Justification for the Focus of the Measure (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-5.pdf
     November 26, 2013 - Graphics for Section 5. Evidence or Other Justification for the Focus of the Measure                                                                                                     Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic …

672. Graphics for Section 6A. Scientific Soundness (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-6-a.pdf
     November 26, 2013 - Graphics for Section 6A. Scientific Soundness                                                                                           Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease …

673. Graphics for Section 8, Feasibility (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-8.pdf
     November 26, 2013 - Graphics for Section 8, Feasibility                                                                                         Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell D…

674. Graphics for Section 7D, Rurality/Urbanicity (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-d.pdf
     November 26, 2013 - Graphics for Section 7D, Rurality/Urbanicity                                                                                             Q‐METRIC Sickle Cell Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for Section VII. Identifica…

675. Q-METRIC Sickle Cell Disease Measure 1 Section 1 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-1.pdf
     October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1 Section 1       Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Graphics for Section I. Basic Measurement Information I.…

676. Sickle Cell Disease, Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-2.pdf
     October 01, 2013 - Sickle Cell Disease, Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Description The percentage of c…

677. Section 8-A, Data Feasibility Tool (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-203-section-8-a-data-feasibility.pdf
     June 02, 2025 - Section 8-A, Data Feasibility Tool EHR Data Feasibility Tool copyright 2011 American Medical Association. All Rights Reserved. This tool and the information contained therein may not be reproduced or distributed and may only be used for collecting data in connection with an agreement with the American Medical As…

678. CPQSC Participating Hospitals (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-203-section-6-a-participating-hospitals.pdf
     June 02, 2025 - CPQSC Participating Hospitals …

679. Section 6-A, Reliability Formula (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-131-section-6-a-reliability-formula.pdf
     June 02, 2025 - Section 6-A, Reliability Formula Reliability formula Reliability = σ2 / (σ2 + V) where σ2 is the systematic variance between hospitals and V is the sampling variance of the sample estimate of a hospital’s rate (both on the probability scale): σ2 = σ 2*p2*(1-p)2 L , where σ 2 L = …

680. Materials Written Statement (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-mats-written-statement.pdf
     June 02, 2025 - Materials Written Statement Submitted 2/27/14 This work was funded by the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Medicare & Medicaid Services (CMS) under the CHIPRA Pediatric Quality Measures Program Centers of Ex…